Found: 7
Select item for more details and to access through your institution.
Maximizing response to intratumoral immunotherapy in mice by tuning local retention.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27390-6
- By:
- Publication type:
- Article
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0248903
- By:
- Publication type:
- Article
Co‐Anchoring of Engineered Immunogen and Immunostimulatory Cytokines to Alum Promotes Enhanced‐Humoral Immunity (Adv. Therap. 7/2022).
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202270013
- By:
- Publication type:
- Article
Co‐Anchoring of Engineered Immunogen and Immunostimulatory Cytokines to Alum Promotes Enhanced‐Humoral Immunity.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 7, p. 1, doi. 10.1002/adtp.202100235
- By:
- Publication type:
- Article
Lack of CD8<sup>+</sup> T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer.
- Published in:
- Science Immunology, 2021, v. 6, n. 64, p. 1, doi. 10.1126/sciimmunol.abi8800
- By:
- Publication type:
- Article
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 498, p. N.PAG, doi. 10.1126/scitranslmed.aaw2614
- By:
- Publication type:
- Article
Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00330
- By:
- Publication type:
- Article